ConductScience.org, home

Paper38014635

Impact of curcumin on ferroptosis-related genes in colorectal cancer: Insights from in-silico and in-vitro studies.

Firouzjaei AA and 6 others. Cell Biochem Funct, 2023. Cited by 22 papers, by iCite.

Cite this record

ConductScience Library. Impact of curcumin on ferroptosis-related genes in colorectal cancer: Insights from in-silico and in-vitro studies. Papers, record 38014635. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38014635

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Impact of curcumin on ferroptosis-related genes in colorectal cancer: Insights from in-silico and in-vitro studies.
PubMed
Journal
Cell Biochem Funct
PubMed
Year
2023
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
22
iCite
Relative citation ratio, by iCite
2.7
iCite
Revised in PubMed
2023-12-16
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Firouzjaei AAAli Ahmadizad
2Aghaee-Bakhtiari SHSeyed Hamid
3Tafti AAli
4Sharifi KKazem
5Abadi MHJNMohammad Hassan Jafari Najaf
6Rezaei SSamaneh
7Mohammadi-Yeganeh SSamirahttps://orcid.org/0000-0003-0430-6325

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CurcuminMajor topic
FerroptosisMajor topic
Colorectal NeoplasmsMajor topic
Humans
Cell Death
Curcuma
Minor Histocompatibility Antigens
Amino Acid Transport System ASC

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Shahid Beheshti University of Medical SciencesPubMed

Source PubMed

Download CSV of grants

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.

PMIDTitleJournalYearIn PapersSource
42426433Exploring the potential role of miR-124 in angiogenesis in colorectal cancer.J Cancer Res Clin Oncol2026https://conductscience.org/library/papers/42426433PubMed
41646939Integrated network pharmacology and experimental verification to reveal the mechanisms of curcumin in the treatment of colorectal cancer.Front Pharmacol2025https://conductscience.org/library/papers/41646939PubMed
41561226Regulation of ferroptosis in colorectal cancer through therapeutic modulation and miRNA targeting.Biochem Biophys Rep2026https://conductscience.org/library/papers/41561226PubMed
41515171Curcumin Rewires the Tumor Metabolic Landscape: Mechanisms and Clinical Prospects.Nutrients2025https://conductscience.org/library/papers/41515171PubMed
41419001Deciphering the rules of regulated cell death subroutines by in silico methods.J Adv Res2026https://conductscience.org/library/papers/41419001PubMed
41155893Tannic Acid/Fe(III)-Coated Curcumin Self-Assembled Nanoparticles for Combination Therapy to Treat Triple-Negative Breast Cancer.Pharmaceutics2025https://conductscience.org/library/papers/41155893PubMed
41040908Discoidin domain receptor tyrosine kinase 2: A new perspective on microenvironment remodeling and targeted therapy of solid tumors (Review).Oncol Lett2025https://conductscience.org/library/papers/41040908PubMed
41008615Natural Compounds as Modulators of Ferroptosis: Mechanistic Insights and Therapeutic Prospects in Breast Cancer.Biomolecules2025https://conductscience.org/library/papers/41008615PubMed
40687235Proteomics-based prognostic signature in colon adenocarcinoma patients with familial adenomatous polyposis.Transl Cancer Res2025https://conductscience.org/library/papers/40687235PubMed
40490812Natural anti-cancer products: insights from herbal medicine.Chin Med2025https://conductscience.org/library/papers/40490812PubMed
40224540Integrating cuproptosis and immunosenescence: A novel therapeutic strategy in cancer treatment.Biochem Biophys Rep2025https://conductscience.org/library/papers/40224540PubMed
39544291The intricate interplay between ferroptosis and efferocytosis in cancer: unraveling novel insights and therapeutic opportunities.Front Oncol2024https://conductscience.org/library/papers/39544291PubMed
39309443Potential Roles and Mechanisms of Curcumin and its Derivatives in the Regulation of Ferroptosis.Int J Biol Sci2024https://conductscience.org/library/papers/39309443PubMed
38874036Computational Discovery of AngiomiRs and Evaluating the Synergistic Effects of Target miRNA with Tranexamic Acid in Colorectal Cancer.Curr Med Chem2025https://conductscience.org/library/papers/38874036PubMed

Download CSV of cited by

Genes10

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38014635

GET https://conductscience.org/api/papers/v1/38014635/authors